Vladimir Eychis, DDS | |
7260 Sunset Blvd, #201, L A, CA 90046-3417 | |
(323) 874-0110 | |
Not Available |
Full Name | Vladimir Eychis |
---|---|
Gender | Male |
Speciality | Dentist |
Location | 7260 Sunset Blvd, L A, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811306244 | NPI | - | NPPES |
B302022 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | B302022 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Vladimir Eychis, DDS 7260 Sunset Blvd, #201, L A, CA 90046-3417 Ph: (323) 874-0110 | Vladimir Eychis, DDS 7260 Sunset Blvd, #201, L A, CA 90046-3417 Ph: (323) 874-0110 |
News Archive
Genmed Holding Corp. has announced its next generic drug registration. The Company will file it's dossier for the drug Suprafen, otherwise known as Ibuprofen, with the Dutch Medicines Evaluation Board in the coming months. Suprafen is a non-steroidal anti-inflammatory as well as an analgesic.
According to a new study published on November 8, 2019, in The Lancet Global Health, a universal diet designed to keep both humans and the earth in good shape has one fatal flaw – more than 1.5 billion people, mostly in the developing world, would have to spend more than they earn to buy that kind of food.
Allarity Therapeutics of Hørsholm, Denmark, today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the "British variant"), at the COVID-19 Testing Service Center (CTSC) of Northern Arizona University's Pathogen and Microbiome Institute (PMI), a leading U.S. infectious disease testing center.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market Lung Optimized Treatment, a new component of the CyberKnife® VSI™ System. The 510(k) clearance enables Accuray to provide physicians with greater flexibility in delivering radiosurgery treatments to patients with lung cancer, the most common and deadly cancer worldwide.
An Independent Committee composed of distinguished members of the Board of Directors of Medifast, Inc. was constituted in February, 2009 to review public allegations of a third party, convicted felon Barry Minkow, and his network of alleged independent experts, posted on Minkow's website alleging illegal activities of Take Shape For Life, Inc., a direct selling company and a subsidiary of Medifast, Inc.
› Verified 7 days ago